◆英語タイトル：Blueprint Medicines Corp (BPMC) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7918
◆発行会社（調査会社）：
GlobalData
◆発行日：2018年10月
◆ページ数：42
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
Summary
Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipeline products include BLU-554, used in advanced hepatocellular carcinoma; avapritinib, used in the treatment for unresectable, treatment-resistant gastrointestinal stromal tumors and advanced systemic mastocytosis; and BLU-667, for ret-mutations, fusions, and predicted resistant mutants. Its preclinical product candidate BLU-782 is intended for ALK2 mutations in fibrodysplasia ossificans progressiva. The company also discovers product candidates for kinase targets and immunokinase targets. The company operates through genomic and cancer research institutions located in the US. Blueprint Medicines is headquartered in Cambridge, Massachusetts, the US.
Blueprint Medicines Corp (BPMC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Blueprint Medicines Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Blueprint Medicines Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Blueprint Medicines Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Blueprint Medicines Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Blueprint Medicines Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Blueprint Medicines Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Blueprint Medicines Raises US$25 Million In Series B Venture Financing 10
Blueprint Medicines Raises US$40 Million In Series A Venture Financing 12
Partnerships 14
Thermo Fisher Scientific Enters into Agreement with Blueprint Medicines 14
Blueprint Medicines Enters into Agreement with QIAGEN Manchester 15
Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems 16
Personal Genome Diagnostics Enters Into Co-Development Agreement With Blueprint Medicines For Novel Kinase Targets 17
Blueprint Medicines Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute And Massachusetts General Hospital Cancer Center 18
Equity Offering 19
Blueprint Medicines Raises USD325.5 Million in Public Offering of Shares 19
Blueprint Medicines Raises USD230 Million in Public Offering of Shares 21
Blueprint Medicines Raises USD143.8 Million in Public Offering of Shares 23
Blueprint Medicines Corp – Key Competitors 25
Blueprint Medicines Corp – Key Employees 26
Blueprint Medicines Corp – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Aug 01, 2018: Blueprint medicines reports second quarter 2018 financial results 28
May 02, 2018: Blueprint Medicines Reports First Quarter 2018 Financial Results 30
Feb 21, 2018: Blueprint Medicines Reports Fourth Quarter and Full Year 2017 Financial Results 32
Oct 31, 2017: Blueprint Medicines Reports Third Quarter 2017 Financial Results 34
Aug 02, 2017: Blueprint Medicines Reports Second Quarter 2017 Financial Results 36
May 03, 2017: Blueprint Medicines Reports First Quarter 2017 Financial Results 37
Mar 09, 2017: Blueprint Medicines Reports Fourth Quarter and Full Year 2016 Financial Results 39
Corporate Communications 41
Oct 10, 2017: Blueprint Medicines Announces Appointment of Christopher Murray, Ph.D. as Senior Vice President, Technical Operations 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Blueprint Medicines Corp, Medical Equipment, Key Facts, 2017 2
Blueprint Medicines Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Blueprint Medicines Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Blueprint Medicines Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Blueprint Medicines Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Blueprint Medicines Corp, Deals By Market, 2012 to YTD 2018 8
Blueprint Medicines Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Blueprint Medicines Raises US$25 Million In Series B Venture Financing 10
Blueprint Medicines Raises US$40 Million In Series A Venture Financing 12
Thermo Fisher Scientific Enters into Agreement with Blueprint Medicines 14
Blueprint Medicines Enters into Agreement with QIAGEN Manchester 15
Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems 16
Personal Genome Diagnostics Enters Into Co-Development Agreement With Blueprint Medicines For Novel Kinase Targets 17
Blueprint Medicines Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute And Massachusetts General Hospital Cancer Center 18
Blueprint Medicines Raises USD325.5 Million in Public Offering of Shares 19
Blueprint Medicines Raises USD230 Million in Public Offering of Shares 21
Blueprint Medicines Raises USD143.8 Million in Public Offering of Shares 23
Blueprint Medicines Corp, Key Competitors 25
Blueprint Medicines Corp, Key Employees 26
Blueprint Medicines Corp, Subsidiaries 27
List of Figures
Blueprint Medicines Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Blueprint Medicines Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Blueprint Medicines Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Blueprint Medicines Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Blueprint Medicines Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Blueprint Medicines Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Blueprint Medicines Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Blueprint Medicines Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
